Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...

Feb 10 | A Fortune 500 company has had a Nashville presence for years. Now it's received top billing, thanks to a… Feb 10 | The deal is poised to break the record for the largest condo purchase ...

With the closing date for handicap entries at the Cheltenham Festival fast approaching, Billy Nash takes a look at some of the Irish novices that have recently met the qualifying criteria.